A major advance in cancer investigation is arising with the use of mini-antibodies to re-engage dysfunctional p53. This crucial cancer protector protein is frequently disabled in several kinds of malignancies, https://topsocialplan.com/story7634873/mini-antibodies-reactivate-the-p53-protein-new-new-pathway-for-cancer-treatment